Paradigm Health Implements New Clinical Trial Solution to Support Observational Study Presented at ASCO
Go back to Paradigm Health Implements New Clinical Trial Solution to Support Observational Study Presented at ASCO| FAIRCHILD SEMICON (NASDAQ: FCS) | Delayed: 19.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.86 | 52 Week High | $21.70 | |||
| Open | $127.70 | 52 Week Low | $12.95 | |||
| Day High | $19.86 | P/E | 496.50 | |||
| Day Low | $19.86 | EPS | $0.04 | |||
| Volume | 62,712 | |||||
